Vacuum Concentrator Centrifuges segmentation by application reveals three dominant end‑use clusters. In biotechnology laboratories, the equipment supports protein precipitation, nucleic‑acid isolation, and metabolite concentration, accounting for roughly 45 % of total revenue because of high assay throughput and frequent method development cycles. Clinical‑diagnostics facilities employ the centrifuges for serum/plasma processing, immunoassay preparation, and point‑of‑care test‑kit manufacturing, representing about 35 % of the market; the segment’s growth is driven by expanding diagnostic panels, the rise of personalized medicine, and regulatory pressure for sample integrity. Pharmaceutical manufacturing utilizes the devices for bulk‑scale solvent removal, API purification, and lyophilization feed‑stock concentration, contributing the remaining 20 % of sales. Furthermore, the biotechnology segment benefits from increasing investment in omics research, which raises the frequency of sample‑concentration steps, whereas clinical diagnostics is propelled by decentralized testing trends, and pharmaceutical manufacturing is linked to scaling biologics pipelines. The relative weight of each application aligns with the chartData below, indicating that biotechnology remains the primary catalyst for adoption while the other two sectors provide steady, ancillary demand.
